- This event has passed.
Webinar | Hep A & B Vaccination Efforts in People Who Inject Drugs
September 10 @ 2:00 pm - 3:00 pm EDT
September 10th at 2 p.m. ET
Despite recommendations for vaccination against hepatitis A virus (HAV) and hepatitis B virus (HBV) for all adults at increased risk of infection, there have been several US states that have reported outbreaks and/or increases in HAV and HBV infections among people who inject drugs in recent years. When not treated, these infections can be highly contagious and can be transmitted through unsafe injecting practices. As part of the overall goal to eliminate viral hepatitis by 2030, it is necessary to increase vaccine uptake through targeted interventions among PWID.
During this webinar, CDC’s NCHHSTP and DVH will provide an overview of their viral hepatitis vaccination recommendations and the recent release of new communications materials encouraging hepatitis A and B vaccination in PWID. Additionally, you will hear from jurisdictions who will speak to their community outreach initiatives to implement hepatitis A and B vaccinations for people who inject drugs. During this webinar, CDC’s DVH will provide an overview of their viral hepatitis vaccination recommendations and their recent launch of new campaign materials. Additionally, you will hear from jurisdictions who will speak to their community outreach initiatives to implement hepatitis A and B vaccinations for people who inject drugs.
To learn more about these resources, please join us on September 10th at 2 p.m. ET for a webinar hosted by the National Alliance of State and Territorial AIDS Directors (NASTAD). The webinar will feature CDC subject matter experts who will discuss the epidemiology of hepatitis A and hepatitis B in people who use and inject drugs and the rationale for the vaccination recommendations. The webinar will also feature several jurisdictions and partner organizations who will share their lessons learned and best practices for reaching and implementing vaccination services in this community.